Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002229183 | SCV000262013 | benign | Ehlers-Danlos syndrome, classic type, 1 | 2024-01-29 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000482273 | SCV000568021 | uncertain significance | not provided | 2024-02-12 | criteria provided, single submitter | clinical testing | Has not been previously published as pathogenic or benign to our knowledge; Not located in the triple helical region, where the majority of pathogenic missense variants occur (PMID: 22696272; HGMD); In silico analysis indicates that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 22696272) |
Mayo Clinic Laboratories, |
RCV000482273 | SCV001716051 | uncertain significance | not provided | 2020-05-12 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002336571 | SCV002638260 | uncertain significance | Familial thoracic aortic aneurysm and aortic dissection | 2022-12-28 | criteria provided, single submitter | clinical testing | The p.I1573V variant (also known as c.4717A>G), located in coding exon 62 of the COL5A1 gene, results from an A to G substitution at nucleotide position 4717. The isoleucine at codon 1573 is replaced by valine, an amino acid with highly similar properties. This amino acid position is highly conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Fulgent Genetics, |
RCV002500661 | SCV002813308 | uncertain significance | Ehlers-Danlos syndrome, classic type, 1; Fibromuscular dysplasia, multifocal | 2021-10-08 | criteria provided, single submitter | clinical testing |